2021
DOI: 10.1016/j.jid.2021.02.006
|View full text |Cite
|
Sign up to set email alerts
|

Cells to Surgery Quiz: April 2021

Abstract: The overall incidence rate is higher in patients with hematologic malignancies. b. Immunopositivity for p63 has been shown to positively predict survival. c. Merkel cell polyomavirus seropositivity at diagnosis is associated with a decreased risk of recurrence. d. A wide local excision with at least 1e2 cm margins of normal-appearing skin is the preferred initial treatment modality for early-stage MCC.e. Avelumab and pembrolizumab are the United States Food and Drug Administration-approved treatments for advan… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Publication Types

Select...

Relationship

0
0

Authors

Journals

citations
Cited by 0 publications
references
References 39 publications
(41 reference statements)
0
0
0
Order By: Relevance

No citations

Set email alert for when this publication receives citations?